Category: Finance
-
Financing Deals: 14 July 2010
Pacific Biosciences in Menlo Park, California, a developer of molecular biology technology, announced completion of a new round of financing worth $109 million. This round includes a previously announced $50 million investment by Gen-Probe Inc., a maker of molecular diagnostic products and services. Hugh Martin, Pacific Biosciences’s chairman and CEO says the funding will be…
-
GE Leads $200 Million Smart Grid Challenge
GE and four venture capital companies unveiled a $200 million innovation challenge for ideas to improve and accelerate a smarter and more efficient electrical grid. The challenge is open to ideas from individuals or teams in business or other sectors. The ideas sought from challenge participants cover three broad themes … Renewable energy Grid efficiency…
-
Financing Deals: 12 July 2010
Accuri Cytometers in Ann Arbor, Michigan completed a $6 million financing deal involving sale of preferred stock to a group of investors including Arboretum Ventures, Baird Venture Partners, Fidelity Biosciences, Flagship Ventures and the InvestMichigan! Program co-managed by Credit Suisse. The company plans to use the financing to expand its C6 brand cytometer into the…
-
U.S. Venture Capital Fundraising Drops by Half
In the second quarter of 2010, 38 venture capital (VC) firms in the U.S. raised $1.9 billion, a decline of 49% compared to the first quarter of 2010 and the lowest level of financial commitments since the third quarter of 2003. These results were reported in a survey released today by National Capital Venture Association…
-
Financing deals, 8 July 2010
Calithera Biosciences in South San Francisco, California today announced completion of a Series A financing totaling $40 million. Series A financing involves early sale of stock to external investors, after initial seed capital. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital taking part. Calithera Biosciences…
-
Financing deals: 7 July 2010
Oragenics, Inc. in Tampa, Florida entered into a common stock purchase agreement with the Koski Family Limited Partnership (KFLP), the company’s largest shareholder. In the deal, Oragenics will sell KFLP 5 million shares of its common stock at $0.40 a share. KFLP will also cancel and exchange for equity a previous $1 million note it…